Symbio Pharmaceuticals Limited
No trades
No trades
Compare with Symbio Pharmaceuticals Limited
−103 JPY
−4.78 B JPY
1.31 B JPY
73.20 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Profile
Sector
Industry
CEO
Fuminori Yoshida
Website
Headquarters
Tokyo
Founded
2005
IPO date
Oct 20, 2011
ISIN
JP3383050006
FIGI
BBG0022KM682
Identifiers
ISIN JP3383050006
SymBio Pharmaceuticals Ltd. engages in the pharmaceutical business. It researches, develops, manufactures, and sells new drugs focusing on the areas of oncology, hematology, and autoimmune diseases. The company was founded by Fuminori Yoshida on March 25, 2005 and is headquartered in Tokyo, Japan.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of 4582 is 69 JPY — it has decreased by −1.43% in the past 24 hours. Watch Symbio Pharmaceuticals Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange Symbio Pharmaceuticals Limited stocks are traded under the ticker 4582.
4582 stock hasn't changed in a week, the month change is a 1.47% rise, over the last year Symbio Pharmaceuticals Limited has showed a −60.34% decrease.
4582 reached its all-time high on May 9, 2013 with the price of 6,320 JPY, and its all-time low was 66 JPY and was reached on Jun 16, 2026. View more price dynamics on 4582 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4582 stock is 5.97% volatile and has beta coefficient of 0.84. Track Symbio Pharmaceuticals Limited stock price on the chart and check out the list of the most volatile stocks — is Symbio Pharmaceuticals Limited there?
Today Symbio Pharmaceuticals Limited has the market capitalization of 5.34 B, it has increased by 6.05% over the last week.
Yes, you can track Symbio Pharmaceuticals Limited financials in yearly and quarterly reports right on TradingView.
Symbio Pharmaceuticals Limited is going to release the next earnings report on Jul 30, 2026. Keep track of upcoming events with our Earnings Calendar.
4582 net income for the last quarter is −2.40 B JPY, while the quarter before that showed −1.21 B JPY of net income which accounts for 0.00% change. Track more Symbio Pharmaceuticals Limited financial stats to get the full picture.
No, 4582 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 19, 2026, the company has 91 employees. See our rating of the largest employees — is Symbio Pharmaceuticals Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Symbio Pharmaceuticals Limited EBITDA is −5.61 B JPY, and current EBITDA margin is −339.59%. See more stats in Symbio Pharmaceuticals Limited financial statements.
Like other stocks, 4582 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Symbio Pharmaceuticals Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Symbio Pharmaceuticals Limited technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Symbio Pharmaceuticals Limited stock shows the sell signal. See more of Symbio Pharmaceuticals Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.